Antiangiogenic therapy can cause malignancy in kidney cancers

November 05, 2020

Angiogenesis is the process by which tumors create new blood vessels that will provide them the nutrients to continue growing. Antiangiogenic drugs specifically block this process. This type of therapy usually has good short-term results, reducing tumor growth. However, several studies suggest that these treatments increase the invasiveness of tumors, and promote more aggressive behavior, inducing a poor prognosis. Studies with animal models have attempted to decipher the molecular mechanisms involved in this discrepancy, but many questions remain unclear.

The team of Dr. Oriol Casanovas from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) has investigated the consequences of antiangiogenic treatment on the invasiveness and metastasis of kidney cancer to identify biomarkers that determine the aggressiveness of these tumors.

In the study published today in the journal EMBO Molecular Medicine, the Casanovas team in collaboration with clinicians from the Hospital de Bellvitge, the Hospital de la Vall d'Hebron, and the VHIO, shows that antiangiogenic drugs, in some cases, increase the aggressiveness of tumors, while in others it is not affected. "These results confirm the heterogeneous effects of antiangiogenic treatments, and how these can profoundly affect the natural progression of tumors and induce malignancy," explains Dr. Casanovas.

Once it had been confirmed the heterogeneity of the response, it was necessary to identify the molecular signals that determine it, and therefore, that would identify the patients who would benefit from the treatment. The study has used various bioinformatics tools for genetic and molecular analyses that have pointed to the involvement of a cell signaling pathway, specifically the ALDH1A3 gene, in the divergent response to antiangiogenic therapy.

Dr. Oriol Casanovas points out that "in this study, we have identified a new biomarker capable of predicting whether a patient may benefit from antiangiogenic treatment", and adds, "these findings may open the door to new targets and therapeutic strategies to suppress the malignancy of these treatments. "

Study tools

To study the tumor behavior with the antiangiogenic treatment, and determine the existing interpatient variation, the researchers created a battery of orthotropic mouse models. These models consist of the implantation of renal tumors biopsies from patients in the same mouse tissue, which reproduce the variability between patients and identifying key aspects of tumor evolution. It is a preclinical tool with great potential. The study of the genes expressed by kidney tumors after treatment with antiangiogenics, and their correlation with the subsequent tumor response, has made it possible to identify the biomarker that can discriminate between invasive and non-invasive tumors.

IDIBELL-Bellvitge Biomedical Research Institute

Related Science Articles from Brightsurf:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.

Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.

Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.

Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.

World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.

PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.

Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.

Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.

Read More: Science News and Science Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to